Movement Disorders+ Summit 2022

Movement Disorders+ Summit 2022

Friday, September 30, 2022
Webinar -- 9:50 AM ET
https://www.clinicaloptions.com/MovementDisordersSummit2022Join1

Agenda

*Tentative Agenda

All times are in Eastern Time.

Day 1: Friday, September 30, 2022
All times are in ET

9:50 AM - 10:00 AM: Welcome Remarks by Chair

10:00 AM - 11:00 AM: Management of Neuropsychiatric Features in Alzheimer’s Disease Dementia

- 5-min break -

11:05 AM - 12:05 PM: Non-CME Educational Talk

- Brief yoga/5-min break -

12:15 PM - 1:15 PM: Targeting CGRP for the Treatment and Prevention of Migraine

- 30 min lunch break –

1:45 PM - 2:45 PM: A Changing Treatment Paradigm of Myasthenia Gravis: A Focus on Novel Targeted Treatments

- 10-min break -

2:55 PM - 3:55 PM: Non-CME Educational Talk

- Brief yoga/5-min break -

4:05 PM - 5:05 PM: Planning Ahead: Development of a Seizure Action Plan With Rescue Medications

- 5-min break -

5:10 PM - 6:10 PM: Diagnosis and Management of Parkinson’s Disease Dementia

6:10 PM - 6:15 PM: Closing Remarks by Chair

 

Day 2: Saturday, October 1, 2022
All times are in ET

9:50 AM - 10:00 AM: Welcome Remarks by Chair

10:00 AM - 11:00 AM: Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders

- 5-min break -

11:05 AM - 12:05 PM: Non-CME Educational Talk

- Brief yoga/5-min break -

12:15 PM - 1:15 PM: Managing Advanced Parkinson’s Disease: Adjunctive Therapies

- 30-min lunch break -

1:45 PM - 2:45 PM: Hyperkinetic Movement Disorders: Importance of Differential Diagnosis When Symptoms Overlap

- 10-min break -

2:55 PM - 3:55 PM: Non-CME Educational Talk

- Brief yoga/5-min break -

4:05 PM - 5:05 PM: Beyond Pharmacotherapy: Advancements in Surgical Therapies for Parkinson’s Disease

- 5 min break -

5:10 PM - 6:10 PM: Updates in Diagnosis and Treatment of Essential Tremor

6:10 PM - 6:15 PM: Closing Remarks by Chair

Faculty

Faculty
Jacqueline French, MD

Professor
Department of Epilepsy/Neurology
NYU Grossman School of Medicine
New York, New York

Faculty
Nada Hindiyeh, MD

Headache Neurologist 

Faculty
Stuart Isaacson, MD

Director
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
Clinical Associate Professor of Neurology
FIU Herbert Wertheim College of Medicine
Miami, Florida

Faculty
Jonathan Katz, MD

Faculty
Daniel E. Kremens, JD, MD

Faculty
Rajesh Pahwa, MD

Chief, Parkinson and Movement Disorder Division
Director, Parkinson Foundation Center of Excellence
University of Kansas Medical Center
Kansas City, Kansas

Faculty
Marwan Sabbagh, MD, FAAN

Professor of Neurology
Alzheimer's and Memory Disorders Division
Department of Neurology
Barrow Neurological Institute
Phoenix, Arizona

 

Faculty
Marta San Luciano, MD, MS, FAAN

Associate Professor of Neurology
University of California, San Francisco
Attending Neurologist
Neurology/Movement Disorders and Neuromodulation Center
University of California, San Francisco Medical Center
San Francisco, California

Faculty
Victor W. Sung, MD

Associate Professor
Division of Movement Disorders
Department of Neurology
University of Alabama at Birmingham
Birmingham, Alabama

Faculty
Gil I. Wolfe, MD, FAAN

Irving and Rosemary Smith Professor and Chairman, SUNY Distinguished Professor
Department of Neurology
University at Buffalo/SUNY Jacobs School of Medicine and Biomedical Services
Buffalo, New York

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of neurological and movement disorders.

Target Audience 
This program is intended for a multidisciplinary audience of neurologists, psychiatrists, primary care physicians, nurses, physician associates/physician assistants, pharmacists, and other members of the healthcare team involved in the management of patients with neurologic and movement disorders.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess the latest advances in treatment options for your patients with neurologic and movement disorders
  • Develop individualized treatment strategies for optimal outcomes in your patients with neurologic and movement disorders
  • Identify best practices for improving patient care

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity will be 10.0 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 10.0 contact hours (1.0 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UANs will be specific to each topic.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate/Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 10.0 continuing education credits for psychologists

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.